28.02.2013 Views

The Principles of Clinical Cytogenetics - Extra Materials - Springer

The Principles of Clinical Cytogenetics - Extra Materials - Springer

The Principles of Clinical Cytogenetics - Extra Materials - Springer

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

<strong>Cytogenetics</strong> <strong>of</strong> Hematologic Neoplasms 407<br />

<strong>The</strong> differences between these two entities involve the clinical features and behavior <strong>of</strong> the disease<br />

and is based largely on the types and proportions <strong>of</strong> noncancerous cells.<br />

Some <strong>of</strong> the common findings in both types <strong>of</strong> HL include the following:<br />

• <strong>The</strong> disease usually arises in a lymph node, virtually in the cellular-rich region, and involves<br />

contiguous rather than disseminated nodes.<br />

• <strong>The</strong> majority <strong>of</strong> deaths occur in young adults.<br />

• Neoplastic tissues usually contain a small number <strong>of</strong> scattered large mononuclear and multinucleated<br />

tumor cells known as Hodgkin’s Reed–Sternberg (H-RS) cells. HL is a unique form <strong>of</strong> cancer,<br />

as affected nodes generally contain a few cancer (H-RS) cells surrounded by many more<br />

noncancerous cells. This ratio might be as high as 1000 to 1.<br />

• T-lymphocytes usually ring the tumor cells in a rosette like manner.<br />

Nodular Lymphocyte Predominant Hodgkin Lymphoma<br />

Nodular lymphocyte predominant Hodgkin lymphoma (NLPHL) represents approximately 5% <strong>of</strong><br />

all Hodgkin lymphomas. It is a B-cell neoplasm with monoclonal proliferation and is characterized<br />

by a nodular or a nodular and diffuse polymorphous proliferation <strong>of</strong> scattered, large, neoplastic cells<br />

known as popcorn cells or lymphocytic and/or histiocytic (L&H) Reed–Sternberg cell variants. <strong>The</strong><br />

usual sites <strong>of</strong> involvement at the time <strong>of</strong> presentation are cervical, axillary, or inguinal lymph nodes.<br />

Patients typically present with a localized proliferative lymphadenopathy.<br />

With morphological exam, lymph node architecture is totally or partially replaced by a nodular or<br />

nodular end diffused infiltrate, predominately consisting <strong>of</strong> small lymphocytes, histiocytes, epithelioid<br />

cells, and intermingled L&H cells. Notably, neutrophils and eosinophils are absent in both nodular and<br />

diffuse regions. With immunophenotyping, L&H cells are positive for CD20, CD79a, BCL6, and CD45<br />

in nearly all cases (245–247). In most instances, they are also Ig J chain and CD75 positive (255).<br />

Organic cation transported 2 (OCT2) is a transcription factor that induces immunoglobulin synthesis<br />

by activating the promoter <strong>of</strong> immunoglobulin genes. Immunolabeling for OCT2 selectively<br />

highlights L&H cells and might become a useful means <strong>of</strong> identifying them (248) and in differenting<br />

between NLPHL and classical Hodgkin lymphoma (249).<br />

<strong>The</strong> L&H cells, in any given case, have identical monoclonally rearranged immunoglobulin genes<br />

(250–252). <strong>The</strong>se rearrangements are usually not detectable in whole-tissue DNA, but only in the<br />

DNA <strong>of</strong> an isolated single islet. <strong>The</strong> variable region <strong>of</strong> the Ig heavy chain shows a significantly high<br />

rate <strong>of</strong> somatic mutations and also shows evidence <strong>of</strong> ongoing mutations. Germinal center B-cells<br />

might be at the blastic stage and are possible cells <strong>of</strong> disease origin. <strong>The</strong> prognosis <strong>of</strong> patients with<br />

early-stage disease is very good, with 10-year survival in more than 80% <strong>of</strong> cases (253).<br />

Classical Hodgkin Lymphoma<br />

Classical Hodgkin lymphoma (CHL) is defined as a monoclonal B-cell neoplasm. <strong>The</strong> cell morphology<br />

is defined as the presence <strong>of</strong> mononuclear and multinucleated Hodgkin’s Reed–Sternberg<br />

cells in an infiltrate containing a variable mixture <strong>of</strong> non-neoplastic small lymphocytes, eosinophils,<br />

neutrophils, histiocytes, plasma cells, fibroblasts, and collagen fibers. <strong>The</strong> immunophenotypic and<br />

genetic features <strong>of</strong> the mononuclear and multinucleated cells are indistinguishable, but the clinical<br />

features and association with EBV show differences (254).<br />

Classical Hodgkin lymphoma accounts for the majority (95%) <strong>of</strong> all HLs and shows a bimodal age<br />

group peak at 15 and 35 years <strong>of</strong> age. Primary involvement in this lymphoma is extranodal. At initial<br />

presentation, about half <strong>of</strong> the patients have stage I or stage II (localized) disease. <strong>The</strong> introduction <strong>of</strong><br />

modern radiation and chemotherapy has made CHL curable in the majority <strong>of</strong> cases.<br />

Approximately 60% <strong>of</strong> patients, the majority <strong>of</strong> them with the nodular sclerosing subtype, usually<br />

have mediastinal infiltrations. Lymph node architecture is replaced by a variable number <strong>of</strong> H-RS<br />

cells mixed with an inflammatory background. Classical diagnostic Reed–Sternberg cells are large,

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!